The expected potential benefits promised by nanotechnology in various fields have led to a rapid increase of the presence of engineered nanomaterials in a high number of commercial goods. This is generating increasing questions about possible risks for human health and environment, due to the lack of an in-depth assessment of the physical/chemical factors responsible for their toxic effects. In this work, we evaluated the toxicity of monodisperse citrate-capped gold nanoparticles (AuNPs) of different sizes (5, 15, 40, and 80 nm) in the model organism Drosophila melanogaster, upon ingestion. To properly evaluate and distinguish the possible dose- and/or size-dependent toxicity of the AuNPs, we performed a thorough assessment of their biological effects, using two different dose-metrics. In the first approach, we kept constant the total surface area of the differently sized AuNPs (Total Exposed Surface area approach, TES), while, in the second approach, we used the same number concentration of the four different sizes of AuNPs (Total Number of Nanoparticles approach, TNN). We observed a significant AuNPs-induced toxicity in vivo, namely a strong reduction of Drosophila lifespan and fertility performance, presence of DNA fragmentation, as well as a significant modification in the expression levels of genes involved in stress responses, DNA damage recognition and apoptosis pathway. Interestingly, we found that, within the investigated experimental conditions, the toxic effects in the exposed organisms were directly related to the concentration of the AuNPs administered, irrespective of their size.
References
[1]
Stone V, Donaldson K (2006) Nanotoxicology: signs of stress. Nat Nanotechnol 1: 23–24.
[2]
Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA (2004) Nanotoxicology. Occup Environ Med 61: 727–728.
[3]
Oberd？rster G, Oberd？rster E, Oberd？rster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113: 823–839.
[4]
Duffin R, Tran L, Brown D, Stone V, Donaldson K (2007) Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19: 849–856.
[5]
Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, et al. (2006) In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40: 4374–4381.
[6]
Nel AE, M？dler L, Velegol D, Xia T, Hoek EMV, et al. (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8: 543–557.
[7]
Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, et al. (2010) Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4: 7481–7491.
[8]
Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, et al. (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105: 14265–14270.
[9]
Warheit DB (2008) How Meaningful are the Results of Nanotoxicity Studies in the Absence of Adequate Material Characterization? Toxicological Sciences 101: 183–185.
[10]
Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM (2008) Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101: 239–253.
[11]
Oberd？rster G (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267: 89–105.
[12]
Boverhof DR, David RM (2010) Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation. Anal Bioanal Chem 396: 953–961.
[13]
Han G, Ghosh P, De M, Rotello VM (2007) Drug and gene delivery using gold nanoparticles. NanoBiotechnology 3: 40–45.
[14]
Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60: 1307–1315.
[15]
Brown SD, Nativo P, Smith J-A, Stirling D, Edwards PR, et al. (2010) Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin. Journal of the American Chemical Society 132: 4678–4684.
[16]
Choi CHJ, Alabi CA, Webster P, Davis ME (2010) Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci USA 107: 1235–1240.
[17]
Kim B, Han G, Toley BJ, Kim C-kyu, Rotello VM, et al. (2010) Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nature Nanotechnology 5: 465–472.
[18]
Wang S, Chen K-J, Wu T-H, Wang H, Lin W-Y, et al. (2010) Photothermal Effects of Supramolecularly Assembled Gold Nanoparticles for the Targeted Treatment of Cancer Cells. Angewandte Chemie International Edition 49: 3777–3781.
[19]
Mu CJ, Lavan DA, Langer RS, Zetter BR (2010) Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. ACS Nano 4: 1511–1520.
[20]
He H, Xie C, Ren J (2008) Nonbleaching fluorescence of gold nanoparticles and its applications in cancer cell imaging. Anal Chem 80: 5951–5957.
[21]
Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, et al. (2010) Metal-based nanoparticles and their toxicity assessment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2: 544–568.
[22]
Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, et al. (2009) Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 5: 701–708.
[23]
Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, et al. (2005) Biocompatibility of Gold Nanoparticles and Their Endocytotic Fate Inside the Cellular Compartment: A Microscopic Overview. Langmuir 21: 10644–10654.
[24]
Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity. Small 1: 325–327.
[25]
Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, et al. (2008) Gold Nanoparticles in Biology: Beyond Toxicity to Cellular Imaging. Accounts of Chemical Research 41: 1721–1730.
[26]
Pernodet N, Fang X, Sun Y, Bakhtina A, Ramakrishnan A, et al. (2006) Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2: 766–773.
[27]
Pan Y, Neuss S, Leifert A, Fischler M, Wen F, et al. (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3: 1941–1949.
[28]
Khan JA, Pillai B, Das TK, Singh Y, Maiti S (2007) Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem 8: 1237–1240.
[29]
Li JJ, Hartono D, Ong C-N, Bay B-H, Yung L-YL (2010) Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 31: 5996–6003.
[30]
Sabella S, Galeone A, Vecchio G, Cingolani R, Pompa PP (2011) AuNPs are toxic in vitro and in vivo: a review. Journal of Nanoscience Letters 1: 145–165.
[31]
Barbara HJ (2011) Drosophila – a versatile model in biology & medicine. Materials Today 14: 190–195.
[32]
Rubin GM, Lewis EB (2000) A brief history of Drosophila's contributions to genome research. Science 287: 2216–2218.
[33]
Adams MD, Sekelsky JJ (2002) From sequence to phenotype: reverse genetics in Drosophila melanogaster. Nat Rev Genet 3: 189–198.
[34]
Rand MD (2010) Drosophotoxicology: the growing potential for Drosophila in neurotoxicology. Neurotoxicol Teratol 32: 74–83.
[35]
Ahamed M, Posgai R, Gorey TJ, Nielsen M, Hussain SM, et al. (2010) Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicol Appl Pharmacol 242: 263–269.
[36]
Demir E, Vales G, Kaya B, Creus A, Marcos R (2011) Genotoxic analysis of silver nanoparticles in Drosophila. Nanotoxicology 5: 417–424.
[37]
Botas J (2007) Drosophila researchers focus on human disease. Nat Genet 39: 589–591.
[38]
Bier E, Reiter LT (2002) Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins. Expert Opinion on Therapeutic Targets 6: 387–399.
[39]
Auluck PK, Chan HYE, Trojanowski JQ, Lee VMY, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295: 865–868.
[40]
Kazantsev A, Walker HA, Slepko N, Bear JE, Preisinger E, et al. (2002) A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nat Genet 30: 367–376.
[41]
Reiter LT, Potocki L, Chien S, Gribskov M, Bier E (2001) A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 11: 1114–1125.
[42]
Chien S, Reiter LT, Bier E, Gribskov M (2002) Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res 30: 149–151.
[43]
Bier E (2005) Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6: 9–23.
[44]
Matthews KA, Kaufman TC, Gelbart WM (2005) Research resources for Drosophila: the expanding universe. Nat Rev Genet 6: 179–193.
[45]
Pompa PP, Vecchio G, Galeone A, Brunetti V, Sabella S, et al. (2011) In Vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster. Nano Research 4: 405–413.
[46]
Sabella S, Brunetti V, Vecchio G, Galeone A, Maiorano G, et al. (2011) Toxicity of citrate-capped AuNPs: an in vitro and in vivo assessment. J Nanopart Res. doi: 10.1007/s11051-011-0590-x (in press).
[47]
Turkevich J, Stevenson PC, Hillier J (1951) A study of the nucleation and growth processes in the synthesis of colloidal gold. Discussions of the Faraday Society 11: 55.
[48]
Frens G (1973) Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions. nature physical science 241: 20–22.
[49]
Zou X, Ying E, Dong S (2006) Seed-mediated synthesis of branched gold nanoparticles with the assistance of citrate and their surface-enhanced Raman scattering properties. Nanotechnology 17: 4758–4764.
[50]
Stremsdoerfer G, Perrot H, Martin JR, Clechet P (1988) Autocatalytic Deposition of Gold and Palladium onto n-GaAs in Acidic Media. Journal of The Electrochemical Society 135: 2881–2886.
[51]
Lee J-S, Stoeva SI, Mirkin CA (2006) DNA-Induced Size-Selective Separation of Mixtures of Gold Nanoparticles. Journal of the American Chemical Society 128: 8899–8903.
[52]
Liu X, Atwater M, Wang J, Huo Q (2007) Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids and Surfaces B: Biointerfaces 58: 3–7.
[53]
Ja WW, Carvalho GB, Mak EM, de la Rosa NN, Fang AY, et al. (2007) Prandiology of Drosophila and the CAFE assay. Proc Natl Acad Sci USA 104: 8253–8256.
[54]
Fortunato JJ, Feier G, Vitali AM, Petronilho FC, Dal-Pizzol F, et al. (2006) Malathion-induced oxidative stress in rat brain regions. Neurochem Res 31: 671–678.
[55]
Royall JA, Ischiropoulos H (1993) Evaluation of 2′,7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 302: 348–355.
[56]
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
[57]
Nel A, Xia T, M？dler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311: 622–627.
[58]
Xia T, Kovochich M, Brant J, Hotze M, Sempf J, et al. (2006) Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6: 1794–1807.
[59]
Xia T, Korge P, Weiss JN, Li N, Venkatesen MI, et al. (2004) Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicity. Environ Health Perspect 112: 1347–1358.
[60]
Foster KA, Galeffi F, Gerich FJ, Turner DA, Müller M (2006) Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol 79: 136–171.
[61]
Vincent A, Crozatier M (2010) Neither Too Much Nor Too Little: Reactive Oxygen Species Levels Regulate Drosophila Hematopoiesis. Journal of Molecular Cell Biology 2: 74–75.
[62]
Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408: 239–247.
[63]
Cho W-S, Cho M, Jeong J, Choi M, Han BS, et al. (2010) Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245: 116–123.
[64]
Yang H, Liu C, Yang D, Zhang H, Xi Z (2009) Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. Journal of Applied Toxicology 29: 69–78.
[65]
Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66: 274–280.
[66]
Feder JH, Rossi JM, Solomon J, Solomon N, Lindquist S (1992) The consequences of expressing hsp70 in Drosophila cells at normal temperatures. Genes Dev 6: 1402–1413.
[67]
Ritossa F (1962) A new puffing pattern induced by temperature shock and DNP in drosophila. Experientia 18: 571–573.
[68]
Laubitz D, Jankowska A, Sikora A, Woliński J, Zabielski R, et al. (2006) Gut myoelectrical activity induces heat shock response in Escherichia coli and Caco-2 cells. Exp Physiol 91: 867–875.
[69]
Franzellitti S, Fabbri E (2005) Differential HSP70 gene expression in the Mediterranean mussel exposed to various stressors. Biochem Biophys Res Commun 336: 1157–1163.
[70]
Lynes MA, Kang YJ, Sensi SL, Perdrizet GA, Hightower LE (2007) Heavy metal ions in normal physiology, toxic stress, and cytoprotection. Ann N Y Acad Sci 1113: 159–172.
[71]
Pratt WB, Toft DO (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228: 111–133.
[72]
Young JC, Agashe VR, Siegers K, Hartl FU (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5: 781–791.
[73]
Arts M-JSJ, Schill RO, Knigge T, Eckwert H, Kammenga JE, et al. (2004) Stress proteins (hsp70, hsp60) induced in isopods and nematodes by field exposure to metals in a gradient near Avonmouth, UK. Ecotoxicology 13: 739–755.
[74]
K？hler H-R, Alberti G, Seniczak S, Seniczak A (2005) Lead-induced hsp70 and hsp60 pattern transformation and leg malformation during postembryonic development in the oribatid mite, Archegozetes longisetosus Aoki. Comp Biochem Physiol C Toxicol Pharmacol 141: 398–405.
[75]
Wu T, Wu Y, Yuan Y, He H, Zhang G (1998) Study on amino acid composition of HSP70 and the level of plasma free amino acids of workers with long-term exposure to harmful factors. J Tongji Med Univ 18: 204–207.
Silbermann R, Tatar M (2000) Reproductive costs of heat shock protein in transgenic Drosophila melanogaster. Evolution 54: 2038–2045.
[78]
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.
[79]
May P, May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621–7636.
[80]
Vousden KH (2002) Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602: 47–59.
[81]
Prives C, Hall PA (1999) The p53 pathway. J Pathol 187: 112–126.
[82]
Sogame N (2003) Drosophila p53 preserves genomic stability by regulating cell death. Proceedings of the National Academy of Sciences 100: 4696–4701.
[83]
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464–468.
[84]
Lee JH, Lee E, Park J, Kim E, Kim J, et al. (2003) In vivo p53 function is indispensable for DNA damage-induced apoptotic signaling in Drosophila. FEBS Lett 550: 5–10.
[85]
Bauer JH, Poon PC, Glatt-Deeley H, Abrams JM, Helfand SL (2005) Neuronal expression of p53 dominant-negative proteins in adult Drosophila melanogaster extends life span. Curr Biol 15: 2063–2068.
[86]
Maier B, Gluba W, Bernier B, Turner T, Mohammad K, et al. (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev 18: 306–319.
[87]
Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, et al. (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45–53.
[88]
Rodriguez A, Oliver H, Zou H, Chen P, Wang X, et al. (1999) Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway. Nat Cell Biol 1: 272–279.
[89]
Kumar S, Doumanis J (2000) The fly caspases. Cell Death Differ 7: 1039–1044.
[90]
Leulier F (2000) The Drosophila caspase Dredd is required to resist Gram-negative bacterial infection. EMBO Reports 1: 353–358.
[91]
Daish TJ, Mills K, Kumar S (2004) Drosophila Caspase DRONC Is Required for Specific Developmental Cell Death Pathways and Stress-Induced Apoptosis. Developmental Cell 7: 909–915.
[92]
Bratton SB, Salvesen GS (2010) Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 123: 3209–3214.
[93]
Verma A, Uzun O, Hu Y, Hu Y, Han H-S, et al. (2008) Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 7: 588–595.
